In the course of their medical practice, the three founders identified a major problem in the healthcare system related to medication errors.
In the NHS in England, the number of medication errors is estimated at 200 million per year. Moreover, ADRs could be a contributory factor to between 1,700 and 22,303 deaths a year.¹
In light of all this, Synapse Medicine (a spin-off from the French National Institute of Health and Medical Research [Inserm] and Bordeaux University Hospital) developed its Medication Intelligence platform within two years of R&D, which is dedicated to improving medication use. Synapse Medicine's technology is therefore used by healthcare professionals such as doctors and pharmacists to help them in their daily work, but also by telemedicine companies, pharmacy groups, insurance companies, hospitals, and healthcare clinics.